A study on prevention of bleeding complications using lusutrombopag for safe RFA in patients with hepatocellular carcinoma with low platelet counts: prospective observational study

A study on prevention of bleeding complications using lusutrombopag for safe RFA in patients with hepatocellular carcinoma with low platelet counts: prospective observational study

Abstract Background Platelet (PLT) transfusion was the most practical way to increase patients’ PLT counts before invasive hepatic procedures such as radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC). A novel drug that raises the PLT count by acting on the thrombopoietin receptor has...

Full description

Bibliographic Details
Main Authors: Hideo Yoshida, Takamasa Ohki, Mineo Kanezaki, Takuma Teratani, Shinpei Sato, Shuntaro Obi, Takahisa Sato, Masatoshi Akamatsu, Koji Uchino, Hiroyoshi Taniguchi
Format: Article
Language:English
Published: BMC 2023-07-01
Series:BMC Gastroenterology
Subjects:
Hepatocellular carcinoma
Platelet count
Radiofrequency ablation
Locolegional therapy
Invasive procedure
Lusutrombopag
Online Access:https://doi.org/10.1186/s12876-023-02879-0

Internet

https://doi.org/10.1186/s12876-023-02879-0

Similar Items